American Portfolios Advisors’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-146
Closed -$4K 3582
2022
Q2
$4K Hold
146
﹤0.01% 2920
2022
Q1
$5.51K Hold
146
﹤0.01% 2912
2021
Q4
$9.07K Hold
146
﹤0.01% 2659
2021
Q3
$12.5K Hold
146
﹤0.01% 2471
2021
Q2
$9.04K Hold
146
﹤0.01% 2574
2021
Q1
$7.12K Buy
+146
New +$7.04K ﹤0.01% 2534

Other funds holding OPRX

American Portfolios Advisors's OPRX Position: Q3 2022 in Review

American Portfolios Advisors sold out of OptimizeRx (OPRX) in Q3 2022, closing a stake of 146 shares — an estimated $4K sold.

American Portfolios Advisors first reported a position in OPRX in Q1 2021 and held it in 6 quarters. The position peaked at $12.5K in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q3 2022.

  • American Portfolios Advisors reported no remaining OptimizeRx position as of Q3 2022 after selling out during the quarter.
  • American Portfolios Advisors sold 146 OptimizeRx shares in Q3 2022, an estimated $4K.
  • American Portfolios Advisors first reported a position in OptimizeRx in Q1 2021 and held it in 6 quarters.
  • American Portfolios Advisors's OptimizeRx position peaked at $12.5K in Q3 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.